Steven L. Bell
1-19 Torrington Place
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 159 publications
Alcohol Intake and Health Study: No Protective Effect at Low Levels, With Mortality Increasing to 1 in 25 at 14 Drinks Per Week.
Journal: Journal of studies on alcohol and drugs
Published: July 08, 2026
Mortality in people with attention-deficit/hyperactivity disorder (ADHD): Examining how risk is embodied in a pooling of two prospective cohort studies.
Journal: medRxiv : the preprint server for health sciences
Published: June 22, 2026
Cognitive function in childhood and cardiovascular disease risk factors up to 6 decades later: Pooled data from two birth cohort studies.
Journal: medRxiv : the preprint server for health sciences
Published: February 09, 2026
Radioxenon calibration, quality control, and intercomparison exercises.
Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
Published: February 05, 2026
Chelation treatment in a novel sub-toxic multi-metal model in rats.
Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine
Published: January 01, 2026
Opioid use disorder and dementia risk: evidence from observational and genetic analyses in diverse ancestry cohorts.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: October 23, 2025
Alcohol use and risk of dementia in diverse populations: evidence from cohort, case-control and Mendelian randomisation approaches.
Journal: BMJ evidence-based medicine
Published: August 03, 2025
Objective measures of auditory temporal resolution with ABR.
Journal: International journal of audiology
Published: April 12, 2025
Risk factors for lung cancer in never-smokers: Multi-cohort study.
Journal: medRxiv : the preprint server for health sciences
Published: March 31, 2025
Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial.
Journal: Nature cancer
Published: February 11, 2025
Last Updated: 09/26/2026